Clinical Trial Update: Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating abatacept for alopecia totalis and alopecia universalis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Totalis
• Alopecia Universalis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Julian M. Mackay-Wiggan | Conditions: Alopecia Totalis/Universalis | Phase 2 | Status: WITHDRAWN